Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

Edith A. Perez, Paul Anthony Ellis|BMC Cancer|2019

Cited by 67